We are committed to commercializing our technology platform by targeting defined disease-associated proteins to solve the unmet needs, including the needs of economically disadvantaged patients. We will achieve our mission by applying the Catabody and E-Vaccine technologies, which generates multiple products for treating and preventing life-threatening diseases. Our lead catabodies focus on healthy aging and age-associated diseases. Our lead E-vaccine has promise for effective prophylaxis and therapy of HIV infection worldwide. Our lead products reflect the potential of the technology platform to generate solutions to major public health challenges.
| Website | http://covalentbioscience.com |
| Revenue | $5 million |
| Employees | 2 (0 on RocketReach) |
| Address | 7707 Fannin St Ste 140, Houston, Texas 77054, US |
| Phone | +1 832-434-0311 |
| Industry | Business Services General, Business Services |
| Keywords | Biotechnology, Drug Development, Pharmaceutical, Protein Therapeutics, Therapeutics, Biopharma, Precision Medicine, Targeted Therapy, Disease Treatment, Clinical Development, Drug Discovery, Biotechnology Research, Medical Research, Life Sciences, Health Technology, Pharmaceutical Research, Biomedical, Patient Care, Unmet Medical Needs |
| Competitors | Thermo Fisher Scientific, MilliporeSigma, Bio-Rad Laboratories, QIAGEN, Promega Corporation, abcam, Enzo Life Sciences, InvivoGen, Bio-Synthesis Inc., Biomol GmbH +44 more (view full list) |
| SIC | SIC Code 873 Companies, SIC Code 87 Companies |
| NAICS | NAICS Code 541 Companies, NAICS Code 541714 Companies, NAICS Code 54171 Companies, NAICS Code 5417 Companies, NAICS Code 54 Companies |
Looking for a particular Covalent Bioscience employee's phone or email?
Covalent Bioscience Questions
The Covalent Bioscience annual revenue was $5 million in 2026.
Covalent Bioscience is based in Houston, Texas.
The NAICS codes for Covalent Bioscience are [541, 541714, 54171, 5417, 54].
The SIC codes for Covalent Bioscience are [873, 87].
